Go back to Press Releases
Sep 03 2012 Press release

New From OSIMPLANT: First Of Its Kind ARAMIS Cervical Disc Prosthesis


Revolutionary Cervical Disc Design Incorporates MOTIS™ High Performance Polymer to Reduce Wear Rate & Extend Service Life

OSIMPLANT today announced its selection of MOTIS™ polymer (from Invibio™ Biomaterial Solutions, the market leader in providing PEEK-based biomaterials to medical device manufacturers around the world), for its CE marked ARAMIS cervical disc prosthesis. The ground-breaking device is the first to incorporate an inlay made from carbon fiber-reinforced MOTIS polymer.

View more details about the device here.

According to OSIMPLANT General Manager Mr Özcan Karadag, the high performing, versatile biomaterial provides new options in articulating devices. This is due to the combination of mechanical strength, creep resistance and wear performance, which are all vital to realizing the ARAMIS’ innovative design potential.

Invibio introduced carbon fiber-reinforced PEEK for structural medical device applications over a decade ago. The successful clinical use has led to their use in articulating devices in knee, finger and spinal applications.

Designed to minimize patient pain and combat such spinal degenerative diseases as Spondylosis and herniated nucleus pulposus, ARAMIS relies on MOTIS’ superior performance properties to advance patient and surgeon benefits. The design of its MOTIS-enhanced inlay, for example, significantly reduces wear rate between the inlay and endplates, thereby prolonging the service life of the implant.

Mr Karadag says that, “During the development phase we considered alternative materials, such as polyethylene and ceramic. Ultimately, however, we selected MOTIS. MOTIS provides a wide range of technological and application benefits that exceed the performance attributes of traditional materials.”

In particular, “The proven benefits — including improved load bearing capabilities and extremely low wear-rate results against hard counterfaces, such as metal — indicate the effectiveness of MOTIS asan alternative to ceramics and UHMWPE in total disc arthroplasty,” said Mr Karadag.

Launched in Europe and the Middle East, in July 2012, the ARAMIS is intended to restore anatomical balance and maintain physiological motion, ranging from flexion/extension, rotation through to lateral bending. Invibio’s MOTIS polymer plays a pivotal role in the successful realization of this innovative device design, with key features that include:

  • Enhanced medical design that is specifically tailored to meet the critical requirements of load bearing applications
  • Highly resistant to creep
  • Extremely low levels of wear debris can be achieved against metal and ceramic counterfaces (compared to traditional materials such as UHMWPE)
  • Proven biocompatibility and biostability enabling safety and implant longevity

“Invibio and OSIMPLANT have a long, successful history of working together. Throughout this partnership, we have received outstanding service from Invibio, including biomaterial expertise, technical and regulatory support,” added Mr Karadag.

Osimplant provides products and services according to needs of the health sector by using innovative technology to meet global market requirements. The company has established a complete quality assurance system to continuously fulfill the requirements according to ISO13485 and CE. These range from material procurement to design development and automated production process.

About Invibio

Invibio is a global leader providing high performance biomaterials, advanced technical research and consultative solutions to medical device manufacturers across a wide range of markets. The company provides medical device manufacturers with PEEK-OPTIMA™ polymer and compounds, MOTIS™ polymer, ENDOLIGN™ composite and PEEK-CLASSIX™ polymer for the development of long- and short-term implantable medical devices.

Invibio Media Contact
Melanie Embery
Invibio Biomaterial Solution
Ph: +44 (0) 1253 89800

Receive the latest clinical evidence and data for PEEK-OPTIMA based applications

By completing this form you are signing up for marketing updates. You will receive targeted messages such as newsletters, tradeshow, webinar and event announcements from Invibio, a member of the Victrex Group or on our behalf. You can unsubscribe at any time. Visit our Privacy Policy to learn more.
The materials on this site are intended for Health Care Professionals and industry users only. If you are a patient, click here, otherwise, click continue.